A Phase 1 Mass Balance Study of Varegacestat
A Phase 1, Open-Label Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of [14C]Varegacestat Following a Single Oral Dose in Healthy Adult Male Participants
Sponsor: Immunome, Inc.
Listed as NCT06845852, this PHASE1 trial focuses on Healthy Volunteer and remains completed. Sponsored by Immunome, Inc., it has been updated 3 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
3 versions recorded-
Oct 2025 — Present [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
-
May 2025 — Oct 2025 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Mar 2025 — May 2025 [monthly]
Recruiting PHASE1
First recorded
Feb 2025
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Immunome, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .